NCT07583563 An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly Status NOT_YET_RECRUITING Phase N/A
NCT07100587 Ketogenic vs. Mediterranean Diet on Metabolic and Hormonal Parameters in Patients With Active Acromegaly Status COMPLETED Phase NA
NCT07037420 ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly Status RECRUITING Phase PHASE2
NCT06930625 A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs Status RECRUITING Phase PHASE3
NCT06607666 Acromegaly Resistant to Conventional Dose of First Generation Somatostatin Ligands Status COMPLETED Phase N/A
NCT06597383 The RApid Switch From 1st Generation Somatostatin Analogues to PaSireOtiDe In Acromegaly Status RECRUITING Phase N/A
NCT06344650 Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess. Status RECRUITING Phase N/A
NCT06326853 Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models Status NOT_YET_RECRUITING Phase N/A
NCT06253897 A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly Status COMPLETED Phase N/A
NCT05964712 Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study Status RECRUITING Phase N/A
NCT05761431 A Single-dose Study of Octreotide Injection in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT05431803 Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China Status COMPLETED Phase N/A
NCT05364944 A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Status TERMINATED Phase PHASE1
NCT05192382 A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2) Status ACTIVE_NOT_RECRUITING Phase PHASE3